Navigation Links
Company Announces Closure of Bluffton, Ohio Plant
Date:9/18/2007

HUTCHINSON, Kan., Sept. 18 /PRNewswire/ -- Collins Industries, a leading manufacturer of specialty vehicles in the United States, announced today the closing of the Mid Bus, Inc. production facility in Bluffton, Ohio. Company officials plan to move the Mid Bus production to their main facility in South Hutchinson, Kansas by November 9, 2007.

"The closure of the Mid Bus production facility in Bluffton, Ohio was certainly a difficult decision. Since the purchase of this company in 1998, we have enjoyed a good relationship with our employees and the community. However, with underutilized manufacturing capacity in our Kansas plant, coupled with recent manufacturing initiatives, we concluded that we could absorb excess volume and alleviate costly duplication of resources through moving the Mid Bus product line to Collins Bus Corporation in South Hutchinson, Kansas," stated Randall Swift, President/CEO of Collins Industries, Inc.

Company officials met with affected employees in the Bluffton, Ohio plant yesterday to announce the impending closure and to explain the intention of providing affected employees first consideration of any employment opportunities for which they are qualified at Collins Bus Corporation.

"As the leading manufacturer of Type-A buses in North America, it is incumbent upon us to continue to look for ways to provide our dealers and customers with the safest and best quality buses in the industry. Over the last nine months, we have made a substantial investment in our Kansas operation, which will allow us to increase our production capacity at the Collins Bus Corporation facility to over 4,000 units annually. We believe these types of changes will allow us to not only sustain our leading position in the Type-A market, but expand our market share and customer base in the coming years," stated Kent Tyler, President of Collins Bus Corporation.

Collins Industries, Inc., a subsidiary of BNS Holding, Inc. (OTC: BNSSA), is a leading manufacturer of ambulances (including medical attack vehicles, rescue vehicles and fire emergency vehicles), North America's largest producer of Type "A" small school buses, the nation's second largest manufacturer of terminal trucks and a leader in the road construction and industrial sweeper markets. Since 1971, the Company has grown to approximately 1000 employees in six plants comprising over one million combined square feet of manufacturing space. The Company sells its products throughout the United States and abroad.

This press release contains forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of assumptions, risks and uncertainties that could cause the actual results of the Company to differ materially from those matters expressed in or implied by such forward-looking statements. They involve known and unknown risks, uncertainties, and other factors, which are in some cases beyond the control of the Company. Additional information regarding these risk factors and uncertainties is described more fully in the Company's SEC filings. A copy of all SEC filings may be obtained from the SEC's EDGAR web site, http://www.sec.gov, or by contacting the company at (401) 848-6300. BNS does not currently maintain a web site.


'/>"/>
SOURCE Collins Industries, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicis Pharmaceutical company enters pediatric market
2. Problems Of a Growing Company
3. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
4. British company developing ‘Safer Cigarettes
5. Australian Company Gets $10 million For Developing Skin Cancer Gel
6. Elderly People Prefer The Company Of Pet Dogs
7. Ossur Acquires the U.S. Orthopaedics Company
8. Britain Approves Indian Company For Supplying Medicines
9. Drug Company Admits Knowledge Of Side Effects In Monkeys
10. Ranbaxy Expands By Acquiring A Generic Company In Belgium
11. Indian Training Company To Train Children In Dubai, Sharjah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: